SIRTeX Medical | EmboCept | Which Medical Device
From Which Medical Device
EmboCept are a new type of starch biodegradeable micropsheres produced by Sirtex in collaboration with Magle Group from Sweden.
Embocept DSM 50 um can be used as an adjuvant in the treatment of inoperable liver and lung carcinoma combined with cytostatic agents.
It's currently licenced for use in Europe, Argentina, Singapore, and Malaysia.
Your opinion matters to others - rate this device or add a comment
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.
